23rd May 2019
There seem to be three options: (1) the UK revokes article 50 and remains in the EU; (2) the UK ratifies the Withdrawal Agreement and exits on that basis; and (3) there is a no deal Brexit. For intellectual property, the impact of each of these three options is different. A considerable amount of work has been done in the UK to prepare for options (2) and (3) and for each scenario we can explain what the effect of Brexit will be for intellectual property.
1st April 2019
The latest summarised guidance from the Office for Life Sciences (OLS): Medilink will continue to publicise all information we receive from OLS and would recommend that you continue to monitor these notices to ensure that you are aware of the very latest information and guidance that could affect your business.
11th March 2019
The latest summarised guidance from the Office for Life Sciences (OLS). Medilink will continue to publicise all information we receive from OLS and would recommend that you continue to monitor these notices to ensure that you are aware of the very latest information and guidance that could affect your business.
28th February 2019
The Secretary of State for Health and Social Care Matt Hancock has written to industry and the life sciences sector about the government’s preparations for a potential no-deal Brexit.
26th February 2019
An EU based Authorised Representatives (EC Rep) may be needed if UK device businesses export devices to markets where a CE mark is required, after the 29th March 2019 deadline.
18th February 2019
Collated guidance for business on no deal preparations, including update on ‘Continued Supply of Medical Devices and Clinical Consumables’ and ‘MHRA Guidance and Publications on a Possible No Deal Scenario’.
13th February 2019
With Brexit looming ever closer and a lot of things remaining unclear (even at this late stage), PIA Commercial have gathered some information to shed some light on the current situation that surrounds the industries that they provide insurance for; the Life Science and Healthcare sectors.
30th January 2019
The Medicines and Healthcare products Regulatory Agency (MHRA) have provided details of legislation to ensure continuity of supply of medicines, medical devices and clinical trials in a no deal Brexit.
8th January 2019
Helping you prepare for EU Exit: Government has now launched a portal to help businesses and citizens prepare for Brexit and has also published ‘The future skills-based immigration system’ white paper setting out its plans to introduce a new single immigration system.
7th December 2018
Matt Hancock, Secretary of State for Health & Social Care, has written a letter to suppliers of medical devices and clinical consumables to update them on the Department’s contingency planning approach.